Simplex Trading’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Simplex Trading’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-23	Closed	–	–	7275
2017 Q3	$0	Sell	23 -3,600	-99%	-$39.7K	﹤0.01%	7202
2017 Q2	$39K	Sell	3,623 -17	-0.5%	-$170	﹤0.01%	2638
2017 Q1	$35K	Buy	3,640 +2,406	+195%	+$24K	﹤0.01%	2716
2016 Q4	$13K	Buy	+1,234	New	+$12.3K	﹤0.01%	3513
2016 Q3	–	Sell	-3,650	Closed	-$39.8K	–	6934
2016 Q2	$47K	Sell	3,650 -1,450	-28%	-$19K	﹤0.01%	2128
2016 Q1	$56K	Buy	+5,100	New	+$45.3K	﹤0.01%	1876
2015 Q4	–	Sell	-1	Closed	-$8	–	6638
2015 Q3	$0	Buy	+1	New	+$9	﹤0.01%	6654
2015 Q1	–	Sell	-3,894	Closed	-$31K	–	6047
2014 Q4	$34K	Buy	+3,894	New	+$31.5K	﹤0.01%	1662

Simplex Trading's SCLN Position: Q4 2017 in Review

Simplex Trading sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 23 shares.

Simplex Trading first reported a position in SCLN in Q4 2014 and held it in 8 quarters. The position peaked at $56K in Q1 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Simplex Trading reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Simplex Trading sold 23 Sciclone Pharmaceuticals Inc shares in Q4 2017.
Simplex Trading first reported a position in Sciclone Pharmaceuticals Inc in Q4 2014 and held it in 8 quarters.
Simplex Trading's Sciclone Pharmaceuticals Inc position peaked at $56K in Q1 2016.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Simplex Trading's 13F filing for Q4 2017, filed 10 Jan 2018.